NASDAQ:AVCO - Avalon GloboCare Corp.
$4.78
 $0.03
+0.63%
4:00PM EDT
2019-04-18
Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable. Exosomes are tiny, subcellular, membrane-bound vesicles 30 to150 nm in diameter that are released by almost all cell types and can carry membrane and cellular proteins, as well as genetic materials that are representative of the cell of origin.Profiling various bio-molecules in exosomes may serve as useful biomarkers for a wide variety of diseases. Its isolation system is designed to be used by researchers for biomarker discovery and clinical diagnostic development, and advancement of targeted therapies. Read more at  reuters.com
sector:  consumer services
industry:  professional services
the data below are updated and published after 9pm EDT each trading day
  AVCO     avg for
industry  
  avg for
sector  
42 stocks weight:  68. 77   63. 88   379. 06  
42 stocks rank:  2. 08 K 2. 16 K 613. 07  

quick ratio:  2. 02   2. 05   0. 99  
current ratio:  3. 17   2. 65   1. 32  

1-yr high:  12. 55   54. 89   544. 14  
last close:  4. 78   45. 93   491. 78  
50-day avg:  4. 45   46. 09   459. 03  
200-day avg:  3. 40   45. 81   460. 57  
1-yr low:  1. 62   37. 83   361. 47  
volume:  52. 72 K 144. 10 K 6. 28 M
50-day avg volume:  265. 17 K 294. 22 K 4. 50 M
200-day avg volume:  240. 09 K 215. 25 K 4. 89 M

1-day return:  0. 63 % -1. 17 % 0. 14 %
this week return:  0. 63 % -0. 29 % 1. 04 %
12-wk return:  13. 00 % 10. 38 % 11. 46 %
52-wk return:  195. 73 % 27. 40 % 13. 76 %

enterprise value (EV):  333. 77 M 1. 02 B 266. 49 B
market cap:  352. 87 M 977. 63 M 254. 05 B
EBITDA:  -7. 16 M 76. 02 M 12. 16 B
enterprise multiple (EV/EBITDA):  -46. 61   4. 95   0. 08  
enterprise/revenue (EV/R):  221. 14   27. 75   9. 58  
total revenue:  1. 51 M 856. 50 M 98. 10 B
total debt:  1000. 00 K 99. 11 M 27. 13 B
debt/equity:  8. 89   18. 85   134. 00  
net income (common):  -7. 77 M 34. 04 M 4. 40 B

shares outstanding:  73. 82 M 30. 63 M 3. 18 B
shares:  22. 32 M 23. 11 M 736. 04 M
shares short:  189. 32 K 508. 25 K 14. 20 M
shares short prior month:  211. 37 K 645. 93 K 12. 80 M
short ratio:  1. 16   2. 26   3. 57  
total cash/share:  0. 03   2. 80   22. 64  
total cash:  2. 25 M 68. 10 M 10. 23 B
free cash flow:  -5. 27 M 128. 67 M 5. 88 B
operating cash flow:  -4. 40 M 47. 49 M 11. 63 B

book value:  0. 17   23. 48   38. 13  
price/book:  28. 97   5. 07   6. 63  
operating margins:  -509. 11 % -54. 96 % 12. 86 %
EBITDA margins:  0. 00 % 9. 14 % 21. 60 %
profit margins:  0. 00 % 9. 68 % 12. 91 %
gross margins:  22. 20 % 32. 94 % 44. 26 %

1-yr max volatility:  124. 11 % --- ---
1-yr mean volatility:  1. 00 % 0. 14 % 0. 06 %

1-yr EPS:  -0. 11   2. 22   8. 30  
P/E:  -44. 26   7. 88   45. 31  
PE/G:  5. 21   2. 61   0. 90  
growth:  -8. 50 % -5. 43 % 14. 49 %
earnings high:  -0. 00   0. 55   2. 18  
earnings avg:  -0. 00   0. 52   1. 80  
earnings low:  -0. 00   0. 48   1. 37  
revenue high:  -0. 00   221. 70 M 25. 42 B
revenue avg:  -0. 00   213. 74 M 25. 05 B
revenue low:  -0. 00   206. 10 M 24. 42 B
return on assets:  -36. 85 % -0. 70 % 6. 82 %
return on equity:  -86. 76 % -3. 41 % 23. 66 %
revenue growth:  -8. 50 % 5. 55 % 11. 04 %
revenue/share:  0. 02   43. 73   142. 58  

beta (1yr vs S&P500):  -0. 76   0. 56   1. 04  
sharpe (1yr):  1. 42   1. 31   0. 93  

held % insiders:  70. 16 % 17. 34 % 13. 96 %
held % institutions:  0. 02 % 75. 38 % 62. 46 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : AVCO
.    + 2.078 =         2.078 :: INITIAL WEIGHT
.   + 37.563 =        39.641 :: spline projection addition
.    x 1.761 =        69.794 :: industry recommendation factor
.    x 4.399 =       307.005 :: EV/R factor
.    x 0.996 =       305.874 :: return on assets factor
.    x 0.991 =        303.22 :: return on equity factor
.    x 0.999 =       302.962 :: revenue growth factor
.    x 2.801 =       848.583 :: current ratio factor
.    x 1.408 =       1194.76 :: quick ratio factor
.    x 1.365 =      1630.342 :: short ratio factor
.    x 2.464 =      4016.557 :: price-to-book factor
.    x 1.213 =      4871.953 :: debt-to-equity factor
.    x 1.381 =      6727.839 :: 5-day avg > 200-day avg
.    x 1.055 =      7097.049 :: 5-day avg > 50-day avg
.    x 1.309 =      9290.693 :: 50-day avg > 200-day avg
.    x 1.021 =      9483.791 :: P/E weight
.    x 0.662 =      6278.208 :: PE/G factor
.    x 1.448 =      9089.836 :: beta factor
.    x 1.416 =     12868.806 :: sharpe factor
.    x 1.414 =     18201.838 :: industry 2-weeks return factor
.    x 0.977 =     17776.301 :: overall "drift" factor
.    x 0.362 =      6429.727 :: largest single-day jump factor
.    x 0.081 =       518.526 :: low price factor
.    x 1.005 =       521.225 :: factor hist industry gain for week 15
.   cubeRoot =         8.048 :: reduced to standardize
.    + 60.72 =        68.767 :: add/subtract for performance
.                     68.767 :: FINAL WEIGHT for NASDAQ:AVCO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org